About
Pharming Group Nv (NASDAQ:PHAR) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 16 2026
Pharming Group announces the 2026 Annual General Meeting of Shareholders
Mar 27 2026
Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older
Mar 24 2026
Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older
Mar 12 2026
Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow
Feb 26 2026
Pharming Group to report fourth quarter and full year 2025 financial results and provide business update on March 12
Financials
Revenue
$376.13 M
Market Cap
$1.16 B
P/E Ratio
415.50
EPS
0.04